Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC

Welcome and Introduction

Date

12 Sep 2022

Session

F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC

Topics

Endocrine Therapy

Tumour Site

Breast Cancer

Presenters

Nick Turner

Authors

N. Turner

Author affiliations

  • London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Q&A

Presenter: Aditya Bardia

Session: F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC

Resources:

Webcast

Close

Presenter: Nick Turner

Session: F. Hoffman-La Roche LTD - What, why and how: Expert review and opinions on the potential of oral SERDs for our patients with HR+ BC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.